Splicing DNA-damage responses to turnour cell death

被引:52
作者
Crighton, D [1 ]
Ryan, KM [1 ]
机构
[1] Beatson Inst Canc Res, Tumor Cell Death Lab, Canc Res UK, Beatson Labs, Glasgow G61 1BD, Lanark, Scotland
来源
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2004年 / 1705卷 / 01期
关键词
apoptosis; tumour development; DNA-damage; chemosensitivity; oncogene; tumour suppressor gene;
D O I
10.1016/j.bbcan.2004.09.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ability of a tumour cell to evade programmed cell death (apoptosis) is crucial in the development of cancer. The process of apoptosis is complex and involves the careful interplay of a host of signalling molecules. Cellular stresses, such as DNA-damage, can initiate apoptosis through multiple pathways, all of which eventually lead to eradication of damaged cells that may otherwise go on to form a tumour. Moreover, the relevance of this to combating cancer is very strong since several therapeutic agents used to treat malignant disease utilize the cells' apoptotic machinery. The purpose of this review is to provide an insight into what we know about how apoptosis is initiated by DNA-damaging agents, how pro- and anti-apoptotic signals converge in the execution of cell death, and how such mechanisms can be perturbed in cancer. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:3 / 15
页数:13
相关论文
共 116 条
[31]   The Li-Fraumeni syndrome: an inherited susceptibility to cancer [J].
Evans, SC ;
Lozano, G .
MOLECULAR MEDICINE TODAY, 1997, 3 (09) :390-395
[32]   A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein [J].
Foray, N ;
Marot, D ;
Gabriel, A ;
Randrianarison, V ;
Carr, AM ;
Perricaudet, M ;
Ashworth, A ;
Jeggo, P .
EMBO JOURNAL, 2003, 22 (11) :2860-2871
[33]   Inhibition of death receptor signaling by FLICE-inhibitory protein as a mechanism for immune escape of tumors [J].
French, LE ;
Tschopp, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :891-893
[34]   Apaf-1 is a mediator of E2F-1-induced apoptosis [J].
Furukawa, Y ;
Nishimura, N ;
Furukawa, Y ;
Satoh, M ;
Endo, H ;
Iwase, S ;
Yamada, H ;
Matsuda, M ;
Kano, Y ;
Nakamura, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) :39760-39768
[35]   The complexity of p53 modulation: emerging patterns from divergent signals [J].
Giaccia, AJ ;
Kastan, MB .
GENES & DEVELOPMENT, 1998, 12 (19) :2973-2983
[36]   Regulated targeting of BAX to mitochondria [J].
Goping, IS ;
Gross, A ;
Lavoie, JN ;
Nguyen, M ;
Jemmerson, R ;
Roth, K ;
Korsmeyer, SJ ;
Shore, GC .
JOURNAL OF CELL BIOLOGY, 1998, 143 (01) :207-215
[37]   Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2 [J].
Gorina, S ;
Pavletich, NP .
SCIENCE, 1996, 274 (5289) :1001-1005
[38]   Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1 [J].
Gostissa, M ;
Hengstermann, A ;
Fogal, V ;
Sandy, P ;
Schwarz, SE ;
Scheffner, M ;
Del Sal, G .
EMBO JOURNAL, 1999, 18 (22) :6462-6471
[39]   Mitochondria and apoptosis [J].
Green, DR ;
Reed, JC .
SCIENCE, 1998, 281 (5381) :1309-1312
[40]  
Gronbaek K, 1998, BLOOD, V92, P3018